Alabdulkarim Dalal A, Almohammed Omar A, Al Ammari Maha A, Almaklafi Nada S, Alkathiri Munirah A, Aljohani Manal A
Pharmaceutical Care Service, Ministry of the National Guard-Health Affairs, Riyadh, Saudi Arabia.
King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
J Geriatr Cardiol. 2020 Dec 28;17(12):775-781. doi: 10.11909/j.issn.1671-5411.2020.12.004.
Hospitalized elderly patients are at high risk of venous thromboembolism (VTE), and the appropriate use of thromboprophylaxis can significantly reduce the incidence of VTE in high-risk patients. We investigated the pattern of VTE prophylaxis administration among elderly medical patients and assessed its appropriateness based on the American College of Chest Physicians (ACCP) recommendations.
A cross-sectional single-center study was conducted between October 2019 and March 2020, including hospitalized (> 48 h), elderly (≥ 60 years), medical patients, and excluding patients receiving anticoagulant for other reason, having contraindication to thromboprophylaxis, or had VTE diagnosed within 48 h. The Padua prediction score was used to determine the patients' risk for VTE, and thromboprophylaxis use was assessed against the ACCP recommendations.
The study included 396 patients with an average age of 75.0 ± 9.01 years, and most patients (71.7%) were classified as high risk for VTE development (Padua score ≥ 4 points). Thromboprophylaxis use was inappropriate in 27.3% of patients, of whom 85.2% were ineligible but still received thromboprophylaxis. Patients who were classified as low risk of VTE were more likely to receive inappropriate thromboprophylaxis (AOR = 76.5, 95% CI: 16.1-363.2), whereas patients with acute infection or rheumatologic disorder were less likely to receive inappropriate thromboprophylaxis (AOR = 0.46, 95% CI: 0.22-0.96).
Although the use of thromboprophylaxis among high-risk elderly patients was reasonably adequate, a large proportion of low-risk patients were exposed to unnecessary risk through inappropriate overutilization of thromboprophylaxis. Thus, healthcare providers should accurately assess patients' risk before prescribing thromboprophylaxis to ensure patient safety.
住院老年患者发生静脉血栓栓塞症(VTE)的风险很高,适当使用血栓预防措施可显著降低高危患者VTE的发生率。我们调查了老年内科患者VTE预防措施的使用模式,并根据美国胸科医师学会(ACCP)的建议评估其合理性。
于2019年10月至2020年3月进行了一项横断面单中心研究,纳入住院(>48小时)、老年(≥60岁)内科患者,排除因其他原因接受抗凝治疗、有血栓预防禁忌证或在48小时内被诊断为VTE的患者。使用帕多瓦预测评分来确定患者发生VTE的风险,并根据ACCP的建议评估血栓预防措施的使用情况。
该研究纳入了396例患者,平均年龄为75.0±9.01岁,大多数患者(71.7%)被归类为发生VTE的高危患者(帕多瓦评分≥4分)。27.3%的患者血栓预防措施使用不当,其中85.2%不符合条件但仍接受了血栓预防措施。被归类为VTE低风险的患者更有可能接受不适当的血栓预防措施(调整后比值比[AOR]=76.5,95%置信区间[CI]:16.1-363.2),而患有急性感染或风湿性疾病的患者接受不适当血栓预防措施的可能性较小(AOR=0.46,95%CI:0.22-0.96)。
虽然高危老年患者血栓预防措施的使用基本合理,但很大一部分低风险患者因不适当的过度使用血栓预防措施而面临不必要的风险。因此,医疗保健提供者在开出血栓预防药物之前应准确评估患者的风险,以确保患者安全。